Global Melanoma Therapeutics Market Assessment of Pipeline Product Innovation and Strategic Consolidations 2017
Mar 9, 2017
Identify commercial opportunities in melanoma deals landscape by analyzing trends in licensing and co-development deals & assessing melanoma therapies that are not yet involved in deals & potential investment opportunities
March 8, 2017 /MarketersMedia/ —
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation report provide information on the emergence over the past decade of novel targeted therapies and therapies that manipulate the immune response has improved treatment options for patients. These new drug classes have been highly commercially successful with blockbuster products that are now well established within the treatment algorithm. First-in-class products account for a considerable proportion of the melanoma pipeline, which is substantially larger than the current market.
Complete report Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation spread across 81 pages is available at: http://www.reportsnreports.com/reports/839645-frontier-pharma-melanoma-therapeutics-cytokine-and-multiple-targeted-small-molecules-and-mabs-dominate-pipeline-and-first-in-class-innovation.html
Scope:
Rising global prevalence and unmet need have resulted in an increase in developmental interest
What is the pathophysiology of melanoma? How has the emergence of new drug classes in the past decade impacted the treatment algorithm? What are the most significant unmet needs within the market?
The melanoma pipeline is large and innovative in comparison with the current market
Which molecule types and molecular targets are most prominent within the pipeline? Which first-in-class targets are most promising? How does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
Do melanoma products attract high deal values? Which molecule types and molecular targets dominate the deals landscape? Which first-in-class pipeline products have no prior involvement in licensing or co-development deals?
Request Sample:
http://www.reportsnreports.com/contacts/requestsample.aspx?name=839645
Reasons to buy:
Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment strategies currently available. Visualize the composition of the melanoma market in terms of the dominant classes of therapies. Unmet needs are highlighted to allow a competitive understanding of current gaps in the market. Analyze the melanoma pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target. There are signs in the pipeline that the industry is seeking novel approaches to meet unmet needs within melanoma.
Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising novel targets have been further reviewed in greater detail. Identify commercial opportunities in the melanoma deals landscape by analyzing trends in licensing and co-development deals and assessing melanoma therapies that are not yet involved in deals, and may be potential investment opportunities.
Get this Report: http://www.reportsnreports.com/purchase.aspx?name=839645
About Us:
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Contact Info:
Name: Ritesh Tiwari
Email: [email protected]
Organization: ReportsandReports
Phone: + 1 888 391 5441
For more information, please visit http://www.reportsnreports.com/reports/839645-frontier-pharma-melanoma-therapeutics-cytokine-and-multiple-targeted-small-molecules-and-mabs-dominate-pipeline-and-first-in-class-innovation.html
Source: MarketersMedia
Release ID: 176200
More News
Chris Steel briefed months ago about Big Splash hotel plans
A ministerial brief is among freedom-of-information documents uncovered.
How pharmacist home visits could save millions while keeping patients well
Pharmacists want to be able to help more patients like Betty.
'Absolutely disgusted': learning supports cut as school budgets slashed
Leaked data shows 58 ACT schools face funding cuts next year.
This federal agency had more managers than workers - until its redundancy round
Agency sheds roles after management ranks exceeded operational workers.
Fat Bear Week is back. Meet the heavyweights vying for the title
The annual contest begins on Sept. 22, the first day of fall, with voting for the carb-loading contenders open to the public until Sept. 29.
Melania Trump says country entering 'technological revolution,' announces new Fostering the Future Together push
Melania Trump says the country is experiencing "an extraordinary moment in human history" at the "threshold of a technological revolution," as she touted new events and partnerships as part of her Fostering the Future Together initiative. "Fostering the Future Together is a global coalition with a unified mission: to empower children through technology and education,"...
ASX set to advance, Wall Street steady; Oil prices slip
Wall Street is holding near its record high in a relatively quiet day for markets worldwide.
‘Rite of passage’: School gambling labelled rife as experts warn of dangers
Students are sneaking off to bet and openly discussing what they’re gambling on as researchers warn it is all too easy for underage teens to set up betting accounts.
How a regional river became the centre of a political storm and international intrigue
From the banks of the Fitzroy River, it’s easy to see why Rockhampton has a reputation for rowing. But hosting tens of thousands of Olympic fans will be a test.
‘News to me’: Inside the suburb flagged as Melbourne’s first walkable neighbourhood
We look at life in the suburb which one of the world’s leading urban planners identified as an example of a future 15-minute city.
Spy pens, eggs on toast and a side of alleged corruption: PI spills the beans to ICAC
The ICAC heard a PI used covert devices hoping to catch out dodgy dealings – but only picked up breakfast orders.
The common item that could see you kicked off these Sydney beaches
A growing number of Sydney councils are drawing a line in the sand over the soaring use of the devices and their ability to record without consent.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.